Guidelines for the management of actinic keratoses

Authors

  • D. De Berker,

    1. Bristol Dermatology Centre, Bristol Royal Infirmary, Bristol BS2 8HW, U.K.
      *Department of Dermatology, St Bartholomew's and the London NHS Trust, London E1 1BB, U.K.
      †Portsmouth Dermatology Centre, St Mary's Hospital, Milton Road, Portsmouth PO3 6AD, U.K.
    Search for more papers by this author
  • J.M. McGregor,

    1. Bristol Dermatology Centre, Bristol Royal Infirmary, Bristol BS2 8HW, U.K.
      *Department of Dermatology, St Bartholomew's and the London NHS Trust, London E1 1BB, U.K.
      †Portsmouth Dermatology Centre, St Mary's Hospital, Milton Road, Portsmouth PO3 6AD, U.K.
    Search for more papers by this author
  • B.R. Hughes,

    1. Bristol Dermatology Centre, Bristol Royal Infirmary, Bristol BS2 8HW, U.K.
      *Department of Dermatology, St Bartholomew's and the London NHS Trust, London E1 1BB, U.K.
      †Portsmouth Dermatology Centre, St Mary's Hospital, Milton Road, Portsmouth PO3 6AD, U.K.
    Search for more papers by this author
  • on behalf of the British Association of Dermatologists Therapy Guidelines and Audit Subcommittee

    1. Bristol Dermatology Centre, Bristol Royal Infirmary, Bristol BS2 8HW, U.K.
      *Department of Dermatology, St Bartholomew's and the London NHS Trust, London E1 1BB, U.K.
      †Portsmouth Dermatology Centre, St Mary's Hospital, Milton Road, Portsmouth PO3 6AD, U.K.
    Search for more papers by this author

Errata

This article is corrected by:

  1. Errata: Corrigendum Volume 158, Issue 4, 873, Article first published online: 18 March 2008

  • Conflicts of interest D. de B., none; J.M.M. has received an honorarium from 3M as an invited member of an advisory board for the treatment of actinic keratoses; B.R.H., none.

  • Members of the British Association of Dermatologists Therapy Guidelines and Audit Subcommittee are: A.D. Ormerod (Chairman), D.J. Eedy, D. Mitchell, F. Humphreys, J. Peters, R. Bull, H. Bell, M. Kouimtzi and S. Jones.

David de Berker.
E-mail: david.deberker@ubht.swest.nhs.uk

Summary

These guidelines stemmed from a consensus meeting held by the British Photobiology Group (BPG) in 1999. Following this meeting one of the authors (J.M.M.) was invited to draw up guidelines for the management of actinic keratoses by the British Association of Dermatologists Therapy Guidelines and Audit Subcommittee. Relevant evidence was sought using the search terms ‘solar keratosis’ and ‘actinic keratosis’ in Medline from 1966 onwards. Additional and earlier literature was reviewed on the basis of references within post-1966 publications. All articles of apparent relevance were reviewed independently of the nature of the publication. The quality of the evidence elicited has been indicated. The National Ambulatory Medical Care Survey (U.S.A.) was used for further data on topical chemotherapy. Papers were reviewed and discussed by the contributors to the BPG Workshop (see Acknowledgments). Recommendations are evidence based where possible. Strength of recommendation is coupled with quality of evidence. Strength of recommendation includes consideration of apparent cost-benefit and practical considerations. Quality of evidence reflects the nature of the trial structure that provides data of efficacy.

Ancillary